6 Defensive Stocks To Buy In 2022 According to Seth Klarman

In this article, we discuss the 6 defensive stocks to buy in 2022 according to Seth Klarman.

Seth Klarman is the man behind Baupost Group, a hedge fund he was asked to run by a group of professors while he was studying for an MBA at Harvard Business School in 1982. He has been at the helm since, currently serving as its chief executive, president and portfolio manager. The 65-year old has established Baupost as one of the most renowned hedge funds on Wall Street, posting an impressive average annual return of more than 20% since being founded. Klarman is personally worth $1.5 billion according to Forbes, and has donated to various philanthropic causes worldwide, including sizeable donations to the Democratic party and causes in Israel.

Klarman follows the ‘value investing’ philosophy of Benjamin Graham, known as the ‘father of value investing’, and has authored a wildly successful book on value investing himself called ‘Margin of Safety: Risk-Averse Value Investing Strategies for the Thoughtful Investor’. He believes in buying assets that are trading below their intrinsic market value, and buying them at a margin of safety for the long-haul. The billionaire has a knack for spotting equities trading at a discount, and has been likened to ‘Oracle of Omaha’ Warren Buffett over the years due to his investment strategy, earning him the moniker ‘Oracle of Boston’.

Let’s Go ‘Value-Hunting’

In an annual letter written to investors in January, of which Business Insider attained a copy, Seth Klarman noted that the market was facing significant threats from burgeoning inflation and rising interest rates. He warned of an incoming crash, stating that the market was characterized by “stretched valuations and deep complacency.” Klarman also informed his investors that Baupost had purchased hedges to protect itself and possibly gain within the current uncertain macro environment. A disjointed market with such peculiar ups-and-downs present value investors a perfect opportunity to go value-hunting, according to Klarman, who sees commercial real estate as a viable investment. He also denounced the idea that Baupost would try to make easy money by betting on the “hottest high-flyers” of the day, rather he underlined a broader investment horizon for his stock picks that ranged from three to five years, not “next week or next quarter.”

Financial Experiment Gone Wrong

The Baupost Group CEO recently spoke to his alma-mater Harvard Business School and discussed a range of themes during a 70-minute webinar. He noted that the Fed doesn’t seem to know what it is doing, and present circumstances are akin to everybody being in a giant financial experiment that seems to be going wrong. He thinks that interest rates are rising as they should, because they had been kept artificially low for a long time. Klarman also contended that the US dollar is here to stay, and competition from the Chinese yuan, Swiss franc, Japanese yen and Euro presents no threat to its status as the global reserve currency.

Seth Klarman also talked in length about the Russian “war of aggression” against Ukraine, and berated Putin for an unnecessary war he has seemingly boxed his military into. The billionaire shared his views on the vast divide in American society, which in his view was beyond the social, economic, and political fractures of society, and stands exacerbated by a changing job market, growing technological divide, and the fact that everyone has a different version of reality due to the democratization of media, or rather the personalization of news.

6 Defensive Stocks To Buy in 2022 According to Seth Klarman

Seth Klarman of Baupost Group

The current economic climate is fraught with many uncertainties and challenges, but investors can find comfort in defensive stocks which offer protection from the worst throes of the market. These stocks usually belong to sectors such as utilities, consumer staples, and healthcare; given that they enjoy strong consumer demand and robust earnings no matter what the economic situation. These companies also often pay dividends, and perform better than the market during a recession. Some examples of defensive stocks include Johnson & Johnson (NYSE:JNJ), The Coca-Cola Company (NYSE:KO), and The Procter & Gamble Company (NYSE:PG). In this article, we’ll focus on defensive stocks to buy according to Seth Klarman.

Our Methodology

After an examination of Baupost Group’s 13F holdings for the first quarter of 2022, we picked 6 defensive stocks in its portfolio, which offer investors a good hedge in the current market situation. To give readers a perspective of what the larger hedge fund industry thinks about each stock, we’ve provided hedge fund sentiment calculated using Insider Monkey’s database of 912 elite hedge funds.

6 Defensive Stocks To Buy in 2022 According to Seth Klarman

6. Noble Corporation (NYSE:NE)

Percentage of Baupost Group’s 13F portfolio: 0.03%

Value of Baupost Group’s Stake: $3.46 million

Number of Hedge Fund Holders: 31

Noble Corporation (NYSE:NE) kicks off the list of defensive stocks to buy according to Seth Klarman. It provides offshore drilling services to the oil and gas companies operating in a variety of terrains around the world. The company has a 20-strong fleet of offshore drilling units, which includes 12 floaters and 8 jackups. Because it is positioned at the heart of the global energy markets, with drilling contracts in the Americas, Europe and Australia, Noble Corporation (NYSE:NE) has rallied 27.24% in the last 12 months, and 20.28% in the year so far as of June 17.

Investors were eager on the company in the first quarter of 2022, where 31 hedge funds owned positions worth $621.7 million, as compared to 24 hedge funds with nearly $374 million worth of stakes a quarter earlier. Seth Klarman’s Baupost Group, in the first quarter, owned approximately 105,000 shares of Noble Corporation (NYSE:NE) with a price tag of $3.46 million.

At the start of June, BTIG analyst Gregory Lewis upgraded Noble Corporation (NYSE:NE) to ‘Buy’ from ‘Neutral’ with a $60 price target. Lewis noted that a recovery in the offshore drilling industry continues to gain momentum, and that NE stock has gained 42% since announcing its merger with offshore drilling company Maersk Drilling in November 2021.

For Q1 2022, Noble Corporation’s (NYSE:NE) revenue of $210.2 million showed a boost of 127.44% in comparison to the year ago quarter, but fell short of analysts’ expectations by $25.9 million. EPS of -$0.12 was also recorded below market estimates by $0.20. 

Like Johnson & Johnson (NYSE:JNJ), The Coca-Cola Company (NYSE:KO), and The Procter & Gamble Company (NYSE:PG), Noble Corporation (NYSE:NE) is a noteworthy defensive stock to buy now.

5. BellRing Brands, Inc. (NYSE:BRBR)

Percentage of Baupost Group’s 13F portfolio: 0.11%

Value of Baupost Group’s Stake: $11.06 million

Number of Hedge Fund Holders: 29

BellRing Brands, Inc. (NYSE:BRBR) deals in the provision of sports nutrition products through its brands Premier Protein, PowerBar, and Dymatize. These include ready-to-drink protein shakes, protein powders, and nutrition bars for athletes. It was previously a business unit of consumer packaged goods company Post Holdings, Inc. (NYSE:POST), another defensive stock in Seth Klarman’s Q1 portfolio.

On May 9, Mizuho analyst John Baumgartner added BellRing Brands, Inc. (NYSE:BRBR) to the firm’s list of top stock picks, noting that it presented one of the rare positive stories for investors in the ongoing market slowdown. He gave the firm an unchanged ‘Buy’ rating and increased the price target to $33 from $30. On the same day, JPMorgan analyst Ken Goldman added BellRing Brands, Inc. (NYSE:BRBR) to the firm’s ‘Analyst Focus List’, noting that the market doesn’t fully appreciate how quickly BellRing’s sales should grow over the next couple years, and thinks that shares are priced attractively given the company’s strong fundamentals. BellRing Brands (NYSE:BRBR) recently announced the launch of a $50 million share repurchase program, with buybacks set to take place within the next two years.

For the first quarter, BellRing Brands, Inc. (NYSE:BRBR) reported an EPS of $0.23, exceeding analysts’ estimates by $0.07. Quarterly revenue of $315.20 million also featured above market forecasts by $7.75 million.

Seth Klarman owned a $11 million position in BellRing Brands, Inc. (NYSE:BRBR) at the end of the first quarter of 2022, consisting of nearly 480,000 shares. Overall, hedge fund sentiment was positive on BRBR stock, with 29 hedge funds reporting ownership of stakes, as compared to 22 hedge funds a quarter earlier.

4. Trilogy Metals Inc. (NYSE:TMQ)

Percentage of Baupost Group’s 13F portfolio: 0.12%

Value of Baupost Group’s Stake: $11.68 million

Number of Hedge Fund Holders: 7

Trilogy Metals Inc. (NYSE:TMQ) is up next on the list of defensive stocks to buy according to Seth Klarman. It operates as a base metals exploration firm, with interests in copper, gold, zinc, silver and other minerals. The Vancouver-based company was previously known as NovaCopper Inc. until it changed its name in 2016. Trilogy Metals Inc. (NYSE:TMQ) owns and develops the Upper Kobuk Mineral Projects in Alaska’s Ambler Mining District.

The firm has suffered in recent months, after the U.S. Department of the Interior filed a motion to remand the final Environmental Impact Statement and suspend the right-of-way permit for the Ambler Access project, after concerns arose regarding the project’s environmental impact. The proposed 211-mile, controlled industrial access road would provide access to the Ambler Mining District in northwestern Alaska, where TMQ holds its primary mining interests. Although this development has raised concerns regarding the project’s completion, Trilogy Metals Inc. (NYSE:TMQ) remains a high risk/reward stock given it has billions of dollars in estimate reserves and a potential change in US administration could put the project back on track. On June 13, National Bank analyst Rabi Nizami reiterated a ‘Sector Perform’ rating on Trilogy Metals Inc. (NYSE:TMQ) shares, and lowered the price target to C$1.75 from C$2.50.

As of the end of the first quarter of 2022, 7 hedge funds reported ownership of stakes in Trilogy Metals Inc. (NYSE:TMQ) with a combined value of $30.45 million. In comparison, 8 hedge funds owned aggregate positions $50.9 million in the company a quarter earlier. Baupost Group’s stake in TMQ at the close of the first quarter stood at 11.12 million shares with a price tag of $11.68 million, representing 0.12% of its total portfolio.

Trilogy Metals Inc. (NYSE:TMQ) is a good defensive stock for investors in 2022, along with names such as Johnson & Johnson (NYSE:JNJ), The Coca-Cola Company (NYSE:KO) and The Procter & Gamble Company (NYSE:PG).

3. Post Holdings, Inc. (NYSE:POST)

Percentage of Baupost Group’s 13F portfolio: 0.28%

Value of Baupost Group’s Stake: $26.2 million

Number of Hedge Fund Holders: 36

Post Holdings, Inc. (NYSE:POST) is a consumer packaged goods company which sells refrigerated, center-of-the-store, food ingredients, and nutrition food products through a range of brands. Despite the recent market sell-off, POST ranks among a number of food retail brands showing strong performance as investors rotate towards defensive stocks. As of June 17, Post Holdings, Inc. (NYSE:POST) has gained 9.53% in the last 6 months, while the S&P500 has slumped nearly 21% over the same period.

On May 9, Piper Sandler analyst Michael Lavery raised the firm’s price target on Post Holdings, Inc. (NYSE:POST) to $96 from $84 and maintained an ‘Overweight’ rating on the company shares. He retained a bullish view on the shares and updated his model to reflect a faster recovery in Foodservice margins, driving his FY2022 EBITDA estimate to the high-end guidance. In June, the company announced that it would invest $110 million to expand its cereal production capacity at its Nevada facility, in order to meet consumer demand, solve capacity constraints, and boost local production for West Coast customers.

Post Holdings, Inc. (NYSE:POST) announced its first quarter earnings on May 5, where EPS was reported at $0.24, outperforming estimates by $0.04. The company raked in $1.41 billion in revenue for the quarter, exceeding Street estimates by $51.4 million. 
36 hedge funds were long Post Holdings, Inc. (NYSE:POST) at the end of March, as compared to 35 hedge funds in the preceding quarter. The aggregate value of Q1 hedge fund holdings stood at $985.8 million. The company’s largest shareholder in the first quarter was Route One Investment Company, with a stake worth nearly $485 million.

Heartland Advisors, an investment firm, talked about the history and performance of Post Holdings, Inc. (NYSE:POST) in its Q1 2021 investor letter. Here’s what it said:

“The run up in equity prices over the past several months has narrowed the pool of attractively valued businesses. Economically sensitive areas of the market, in particular, have seen valuations stretched—but the impact of investor exuberance is evident in share prices of companies throughout the broader market. In response, we continue to focus on finding and owning companies that are poised to succeed against a variety of backdrops or those that are priced at significant discounts to peers regardless of the sector or industry. Recent addition Post Holdings, Inc. (POST) is an example of the type of business we’ve found attractive.

Post manufactures and markets food products through five business lines including a breakfast cereals unit, a food service division, refrigerated retail products, and active nutrition. Shares of the company came under pressure due to the severe impact the COVID-19 economic shutdown had on its food service segment.

Additionally, investors were wary of the company’s use of debt given the uncertainty surrounding how long the economic pullback would last. The bear case against the stock, in our view, is overblown.

In recent years, Post has transformed itself into a higher-growth packaged food enterprise with a diversified portfolio that, taken as a whole, possesses superior growth and free cash flow characteristics vs. its peers. Despite this, shares sell at a meaningful discount to the peer group based on enterprise value/earnings before interest taxes depreciation and amortization, as well as our estimates of the company’s intrinsic value. As the economy returns to normal, Post’s food service line should rebound, and we believe investors will gain a greater appreciation of the company and its stock.”

2. Archaea Energy Inc. (NYSE:LFG)

Percentage of Baupost Group’s 13F portfolio: 0.7%

Value of Baupost Group’s Stake: $65.48 million

Number of Hedge Fund Holders: 32

Archaea Energy Inc. (NYSE:LFG) is a Texas-based energy firm which deals in the production of renewable natural gas (RNG) by processing waste emissions from landfills.

Barclays analyst Theresa Chen initiated coverage of Archaea Energy Inc. (NYSE:LFG) with an ‘Overweight’ rating and a $26 price target on June 17. Archaea is a leading RNG company with long-term contracts that highlight its massive growth potential, according to Chen, who views the macro backdrop for RNG as being “highly constructive,” with demand set to double by 2030. She pointed out that Archaea Energy Inc. (NYSE:LFG) has a backlog of 88 top-notch RNG development projects for which gas rights agreements have already been signed, with 32.5 years of average remaining life. As of June 17, LFG stock has posted gains of 12.59% in the last 12 months, and 8% in the last month alone.

For the first quarter of 2022, Archaea Energy Inc. (NYSE:LFG) reported an EPS of $0.15, beating Street estimates by $0.09. However, quarterly revenue of $56.9 million fell below consensus estimates by $8.9 million.

With 3.12 million shares valued at around $65.5 million, Archaea Energy Inc. (NYSE:LFG) stock represented 0.7% of Seth Klarman’s first quarter portfolio. Overall, investors were eager on the unique energy company, with 32 hedge funds reporting bullish bets, as compared 26 hedge funds in the previous quarter.

1. Encompass Health Corporation (NYSE:EHC)

Percentage of Baupost Group’s 13F portfolio: 2.29%

Value of Baupost Group’s Stake: $213.33 million

Number of Hedge Fund Holders: 48

Encompass Health Corporation (NYSE:EHC) is one of the best defensive stocks to buy according to Seth Klarman, who increased his stake in the firm by 319% in the first quarter to stand at 3 million shares priced at $213.3 million. Healthcare stocks with well-established business models and stable earnings provide investors a safe place to park their money in times of economic slowdown. Encompass Health Corporation (NYSE:EHC) provides post-acute healthcare services through its segments: Inpatient Rehabilitation, and Home Health and Hospice. The firm has a market cap of $5.63 billion, and offers a stable dividend yield of 1.99% as of June 17.

Raymond James analyst John Ransom on June 17 reiterated a ‘Strong Buy’ rating on Encompass Health Corporation (NYSE:EHC) shares, and revised the price target to $70 from $85. The company recently provided separate guidance for both its segments, ahead of the planned spinoff of its ‘Enhabit’ home health and hospice segment on July 1, which will form an independent company under the ticker EHAB. The analyst noted that the company’s updated 2022 EBITDA guidance came in around $17 million lower than his estimates on an adjusted basis.

Encompass Health Corporation (NYSE:EHC) disclosed EPS of $0.97 for the first quarter, outperforming estimates by $0.05. The company’s revenue of $1.33 billion for the quarter also beat analysts’ forecasts by $8.7 million.

A total of 48 hedge funds were invested in Encompass Health Corporation (NYSE:EHC) at the end of the first quarter, with $1.14 billion in collective stakes. This shows improving investor confidence over the previous quarter, where 40 hedge funds reported long bets on the company shares.

Heartland Advisors, an investment management firm, talked about the prospects of  Encompass Health Corporation (NYSE:EHC) in its Q4 2021 investor letter. Here’s what the fund said:

COVID complications. Shares of many Health Care companies lagged as the continuing threat of COVID-19 dampened demand for elective medical procedures and health care providers struggled to maintain adequate staffing in the face of burnout and resistance to vaccine mandates. The Strategy’s holdings in the sector trailed the benchmark average, and the group contained a key detractor, Encompass Health Corporation (EHC).

Encompass provides inpatient rehabilitation services as well as home-based health and hospice care. Both businesses enjoy a competitive advantage over many of their peers and, we believe, are well positioned to grow organically, and acquire smaller competitors that could further economies of scale.

A labor shortage has taken a toll on sales and profit margins at Encompass as the company struggles to fill positions in a challenging environment for nursing wages and availability. Revenues have also been hurt by a slowdown in elective surgeries performed, which results in a smaller pool of patients in need of rehabilitation services.

When we took a stake in Encompass late in the summer of 2020, we recognized that COVID-related headwinds could endure longer than anticipated. However, the team believes the current challenges will eventually fade as enhanced nurse recruiting outreach helps mitigate staffing pressures while COVID-19 containment and treatment efforts gain traction. With shares producing an 8% free cash flow yield and trading at just 9x 2022 enterprise value/earnings before interest, taxes, depreciation, and amortization, we believe our patience will be rewarded.”

You can also take a look at 15 Best Undervalued Stocks to Buy Now and 10 Biggest Quant Funds in The World.